Research Tree Research Tree Logo

  • Try our Investor Tool
  • Login
  • Sign Up
  • Providers
  • Companies

Research Tree Logo

  • Login
  • Sign Up
  • Features
  • Pricing
  • RNS/News
  • Contact
  • Try our Investor Tool
  • Login
  • Sign Up
  • Providers
  • Companies
  • Features
  • Pricing
  • RNS/News
  • Short Interest Tracker
  • Blogs
    • Academy
    • Insights
    • News
    • Research Tree
    • The Naked Fund Manager
  • Ideas & Picks
    • Ideas Hub
    • Stock Pick League
    • Themes & Screens Hub
  • Explore Content
    • Regions
      UK Rest of EMEA N America APAC LatAm
    • Sectors
      Automobile Industry Banks Building & Construction Chemicals Discretionary Personal Goods Discretionary Retail Energy Financial Services Food & Drink Food Production Health Household Goods & DIY Industrial Equipment, Goods & Services Insurance & Reinsurance Leisure, Tourism & Travel Media Other Real Estate Resources Staple Retail Technology Telecoms Trusts, ETFs & Funds Utilities
    • Small / Large Cap
      UK100 UK250 UK Smallcap UK Other Main Markets Other
    • Private/EIS
      EIS Single Company EIS/SEIS Funds IHT Products SEIS Single Company VCT Funds
  • Providers
    • Free/Commissioned
      Align Research BRR Media Capital Access Research Edison Equity Development Fidante Partners Five Minute Pitch TV goetzpartners securities Limited Hardman & Co Independent Investment Research Kepler | Trust Intelligence piworld.co.uk Proactive Progressive Equity Research QuotedData Radnor Capital Partners Research Tree Trinity Delta
    • High Net Worth Offering
      Allenby Capital AlphaValue Arden Partners Cenkos Securities Dowgate Capital finnCap First Berlin GMP FirstEnergy Hybridan Liberum Louis Capital Marten & Co Medley Global Advisors N+1 Singer Northland Capital Partners SP Angel Stanford Capital Partners Stockdale Securities Tamesis Partners The Life Sciences Division VSA Capital WHIreland Whitman Howard Zeus Capital
    • Institutional Offering
      Align Research Allenby Capital AlphaValue Arden Partners BRR Media Bryan, Garnier & Co Capital Access Research Cenkos Securities Dowgate Capital Edison Equity Development Fidante Partners finnCap First Berlin Five Minute Pitch TV GMP FirstEnergy goetzpartners securities Limited Hardman & Co Hybridan Independent Investment Research Kepler | Absolute Hedge Kepler | Trust Intelligence Liberum Longspur Research N+1 Singer Northland Capital Partners piworld.co.uk Proactive Progressive Equity Research QuotedData Radnor Capital Partners Research Tree Shore Capital SP Angel Stanford Capital Partners Stifel Stockdale Securities Tamesis Partners The Life Sciences Division Trinity Delta VSA Capital WHIreland Whitman Howard Zeus Capital
    • Video/Audio Interviews
      BRR Media Edison Equity Development Five Minute Pitch TV piworld.co.uk Proactive Research Tree
  • Contact
Companies >
Germany >
Pharmaceuticals >
STADA Arzneimittel >
Research >
H1 16: well on track for FY guidance

  • 04 Aug 2016

H1 16: well on track for FY guidance


STADA Arzneimittel | SAZ | 0 0 (-0.1%) | Mkt Cap: 5,400m


  • AlphaValue
    • Fabrice Farigoule

    • 2 pages

Pharmaceuticals image


 
Pharmaceuticals image


Revenues were up +1% to 1,037.4m, reported EBITDA +11% to €200.7m (adjusted +7%), operating income +22% to €136.3m (+11% adjusted) and net income +53% to 82m (+13% adjusted). Net debt reached €1,211.3m vs €1,216m at year-end 15. Management confirmed its outlook for FY16, according to which slight growth in sales adjusted for currency and portfolio effects, adjusted EBITDA and adjusted net income is to be expected. Looking further ahead, the group anticipates sales of &euro ....


Sign up to access

Get access to our full offering from over 30 providers

Get access to our full offering from over 30 providers


Get Started
Already a member? Log in here
See all the research we have on this company.

More Content

More Content

End of coverage

Companies: STADA Arzneimittel

AlphaValue

Q1 16: not too bad...

Companies: STADA Arzneimittel

AlphaValue

Waving good-bye

Companies: STADA Arzneimittel

AlphaValue

FY15 in line. Russia still a worry for FY16

Companies: STADA Arzneimittel

AlphaValue

Strong profitability push

Companies: STADA Arzneimittel

AlphaValue

Useful Links

  • Features
  • Pricing
  • RNS/Newswires Feeds
  • Providers Hub
  • Company Hub

Account

  • Login
  • Free Trial - Join Now
  • Contact
Follow us on Linkedin Follow us on Twitter

Share:

Heap | Mobile and Web Analytics

Copyright © 2019 Research Tree | All Rights Reserved. | Terms of Service and Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Tools licensed and contents implemented and optimized by Digital Look Ltd.

DigitalLook |Web Financial Group

©1999-2013 – Digital Look Ltd. A Web Financial Group Company All rights reserved. Legal notice.

Top
  • Home
  • Features
  • Pricing
  • RNS/News
  • Short Interest Tracker
  • Blogs
    • Academy
    • Insights
    • News
    • Research Tree
    • The Naked Fund Manager
  • Ideas & Picks
    • Ideas Hub
    • Stock Pick League
    • Themes & Screens Hub
  • Explore Content
    • Regions
      • UK
      • Rest of EMEA
      • N America
      • APAC
      • LatAm
    • Sectors
      • Automobile Industry
      • Banks
      • Building & Construction
      • Chemicals
      • Discretionary Personal Goods
      • Discretionary Retail
      • Energy
      • Financial Services
      • Food & Drink
      • Food Production
      • Health
      • Household Goods & DIY
      • Industrial Equipment, Goods & Services
      • Insurance & Reinsurance
      • Leisure, Tourism & Travel
      • Media
      • Other
      • Real Estate
      • Resources
      • Staple Retail
      • Technology
      • Telecoms
      • Trusts, ETFs & Funds
      • Utilities
    • Small / Large Cap
      • UK100
      • UK250
      • UK Smallcap
      • UK Other Main Markets
      • Other
    • Private/EIS
      • EIS Single Company
      • EIS/SEIS Funds
      • IHT Products
      • SEIS Single Company
      • VCT Funds
  • Providers
    • Free/Commissioned
      • Align Research
      • BRR Media
      • Capital Access Research
      • Edison
      • Equity Development
      • Fidante Partners
      • Five Minute Pitch TV
      • goetzpartners securities Limited
      • Hardman & Co
      • Independent Investment Research
      • Kepler | Trust Intelligence
      • piworld.co.uk
      • Proactive
      • Progressive Equity Research
      • QuotedData
      • Radnor Capital Partners
      • Research Tree
      • Trinity Delta
    • High Net Worth Offering
      • Allenby Capital
      • AlphaValue
      • Arden Partners
      • Cenkos Securities
      • Dowgate Capital
      • finnCap
      • First Berlin
      • GMP FirstEnergy
      • Hybridan
      • Liberum
      • Louis Capital
      • Marten & Co
      • Medley Global Advisors
      • N+1 Singer
      • Northland Capital Partners
      • SP Angel
      • Stanford Capital Partners
      • Stockdale Securities
      • Tamesis Partners
      • The Life Sciences Division
      • VSA Capital
      • WHIreland
      • Whitman Howard
      • Zeus Capital
    • Institutional Offering
      • Align Research
      • Allenby Capital
      • AlphaValue
      • Arden Partners
      • BRR Media
      • Bryan, Garnier & Co
      • Capital Access Research
      • Cenkos Securities
      • Dowgate Capital
      • Edison
      • Equity Development
      • Fidante Partners
      • finnCap
      • First Berlin
      • Five Minute Pitch TV
      • GMP FirstEnergy
      • goetzpartners securities Limited
      • Hardman & Co
      • Hybridan
      • Independent Investment Research
      • Kepler | Absolute Hedge
      • Kepler | Trust Intelligence
      • Liberum
      • Longspur Research
      • N+1 Singer
      • Northland Capital Partners
      • piworld.co.uk
      • Proactive
      • Progressive Equity Research
      • QuotedData
      • Radnor Capital Partners
      • Research Tree
      • Shore Capital
      • SP Angel
      • Stanford Capital Partners
      • Stifel
      • Stockdale Securities
      • Tamesis Partners
      • The Life Sciences Division
      • Trinity Delta
      • VSA Capital
      • WHIreland
      • Whitman Howard
      • Zeus Capital
    • Video/Audio Interviews
      • BRR Media
      • Edison
      • Equity Development
      • Five Minute Pitch TV
      • piworld.co.uk
      • Proactive
      • Research Tree
  • Contact
  • Sign Up
  • Sign In